For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment, and this rate can be higher for patients with more advanced stages of the cancer. While ...
Dec 29, 2023
0
67
(HealthDay)—Acupuncture may cut joint pain among postmenopausal women with early-stage breast cancer and aromatase inhibitor-related pain, according to a study published in the July 10 issue of the Journal of the American ...
Jul 30, 2018
0
349
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
Sep 15, 2016
0
3
The spread of malignant cells around the body, known as metastasis, is the leading cause of mortality in women with breast cancer.
Sep 19, 2016
0
291
Loyola Medicine and Palos Health are offering a new breast cancer radiation therapy that shortens the treatment time by three weeks, while reducing side effects.
Apr 15, 2019
0
12
Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco ...
Aug 25, 2016
0
79
Many breast cancer patients who have a mastectomy will consider breast reconstruction. But for a portion of these women, radiation therapy is also recommended - and that can alter the tissue around the breast, impacting reconstruction ...
Dec 8, 2016
0
2
A large retrospective study conducted by physician researchers from Roswell Park Comprehensive Cancer Center reports benefits of chemotherapy for many patients with early-stage breast cancer with rare variant histology, or ...
Apr 18, 2023
0
2
For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research.
May 17, 2018
0
9
A researcher from University Hospitals Seidman Cancer Center will discuss his upcoming immunotherapy clinical trial for triple-negative breast cancer at the 2016 San Antonio Breast Cancer Symposium. The annual symposium is ...
Dec 9, 2016
0
10
